Nektar upgraded at Oppenheimer on upcoming mid-stage trial readout
Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...
Nektar Therapeutics (NASDAQ:NKTR) Stock Rating Upgraded by Oppenheimer
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Oppenheimer cut Sutro to Perform, says ‘not too surprised’ with restructuring
Oppenheimer analyst Jay Olson downgraded Sutro Biopharma (STRO) to Perform from Outperform after the company reported Q4 results and announced ...
Oppenheimer Could Have Been A Netflix Hit? Streaming Giant’s CCO Claimed It Didn’t Need Theaters To Succeed
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Jewish Telegraphic Agency3d
The Jewish story behind ‘Oppenheimer,’ explained
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
‘Dexter: Resurrection’ Casts David Dastmalchian In Guest Star Role
Showtime has cast David Dastmalchian ( Oppenheimer) in Dexter: Resurrection in the guest starring role of “Gareth.” ...
Amgen data ‘muddies’ outlook for Cartesian, says Oppenheimer
Oppenheimer reiterates a Perform rating on Cartesian Therapeutics (RNAC) without a price target following the company’s Q4 report. The ...
Goldman's Oppenheimer warns U.S. stock market may continue to underperform
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Netflix Junkie on MSN12h
'Oppenheimer' vs 'Odyssey': Which Recent Christopher Nolan Flick Takes The Crown for Most Star Studded Cast?
Who wins between Oppenheimer and The Odyssey for the most star-studded cast amongst Christopher Nolan's films?